Stock Events

Stock Events

Lumos Diagnostics 

$0.062400
11
-$0.01-10.86%Monday 15:04

Statistics

Day High
0.0893
Day Low
0.0795
52W High
0.24
52W Low
0.0576
Volume
34,400
Avg. Volume
18,337
Mkt Cap
58.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 2019
$0.01
May 2019
$0.01
Sep 2018
$0.01
May 2018
$0.01
Sep 2017
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Aug 24Expected
Q4 2023
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.02
-0.02
-0.01
0
Expected EPS
-0.013885141011118107
Actual EPS
0

Financials

-37.54%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
13.19MRevenue
-4.95MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LDXHF. It's not an investment recommendation.
Woodside Energy Group
3
WDS.AU
Stakk
3
SKK.AU
XRP
2
XRP.CRYPTO
DroneShield Limited
2
DRO.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories offers a broad range of diagnostics products, including rapid diagnostics which compete directly with Lumos Diagnostics' offerings.
QuidelOrtho
QDEL
Mkt Cap738.56M
Quidel Corporation specializes in diagnostic healthcare solutions similar to Lumos Diagnostics, particularly in the areas of infectious disease testing.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories, Inc. produces and supplies products and systems used for diagnostic testing, which overlaps with the market Lumos Diagnostics serves.
Quest Diagnostics
DGX
Mkt Cap25.75B
Quest Diagnostics is a provider of diagnostic information services, which includes products that compete in the same space as Lumos Diagnostics.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector, offering diagnostic and testing solutions.
Orasure Technologies
OSUR
Mkt Cap273.46M
OraSure Technologies, Inc. develops, manufactures, and markets point-of-care diagnostic tests, directly competing with Lumos Diagnostics' rapid test kits.
Neogenomics
NEO
Mkt Cap2.37B
NeoGenomics Laboratories specializes in cancer diagnostics and pharma services, providing diagnostic solutions that could overlap with Lumos' offerings.
Fulgent Genetics
FLGT
Mkt Cap591.03M
Fulgent Genetics offers genetic testing to detect diseases, indirectly competing with Lumos Diagnostics by providing alternative diagnostic solutions.

About

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Show More
CEO
Douglas Ward
Employees
15
Country
Australia
ISIN
AU0000157091
WKN
000A3CYYM

Listings

F
DE
7YU.F
OTC Link
US
LDXHF
AU
AU
LDX.AU

0 Comments

Share your thoughts

FAQs

What is Lumos Diagnostics stock price today?▼
The current price of LDXHF is $0.06 USD — it has decreased by -10.86% in the past 24 hours. Watch Lumos Diagnostics stock price performance more closely on the chart.
What is Lumos Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Lumos Diagnostics stocks are traded under the ticker LDXHF.
Is Lumos Diagnostics stock price growing?▼
LDXHF stock has risen by +0% compared to the previous week, the month change is a -10.86% fall, over the last year Lumos Diagnostics has showed a -43.27% decrease.
What is Lumos Diagnostics market cap?▼
Today Lumos Diagnostics has the market capitalization of 58.93M
When is the next Lumos Diagnostics earnings date?▼
Lumos Diagnostics is going to release the next earnings report on March 4, 2027.
What were Lumos Diagnostics earnings last quarter?▼
LDXHF earnings for the last quarter are 0 USD per share, whereas the estimation was -0.01 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lumos Diagnostics revenue for the last year?▼
Lumos Diagnostics revenue for the last year amounts to 13.19M USD.
What is Lumos Diagnostics net income for the last year?▼
LDXHF net income for the last year is -4.95M USD.
Does Lumos Diagnostics pay dividends?▼
Yes, LDXHF dividends are paid semi-annual. The last dividend per share was 0.3 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Lumos Diagnostics have?▼
As of October 13, 2026, the company has 15 employees.
In which sector is Lumos Diagnostics located?▼
Lumos Diagnostics operates in the Health & Wellness sector.
When did Lumos Diagnostics complete a stock split?▼
Lumos Diagnostics has not had any recent stock splits.
Where is Lumos Diagnostics headquartered?▼
Lumos Diagnostics is headquartered in Carlsbad, Australia.